Pharmacy Financing Ireland: Funding a Practice Purchase or Fit-Out (2026)
Alan Bermingham
10 Years in non banking finance
Published:
Pharmacy is one of the most bankable businesses in Ireland, and one of the most frequently turned down. Lenders get nervous about the price of a practice, the cost of stock and the wait on health-scheme payments, and they forget that a community pharmacy throws off some of the steadiest revenue going.
So here is the real picture. This guide covers exactly how pharmacy financing works in Ireland in 2026, whether you are buying an established practice, opening from scratch or upgrading the dispensary, which lenders suit which situation, and what you need to walk in prepared and walk out approved.
- Acquiring an established pharmacy runs €150,000 to €300,000, and an acquisition loan over 7 to 10 years spreads goodwill, inventory and equipment into one manageable repayment.
- Dispensing systems, automated counters and refrigeration are funded through asset finance, so the kit secures the loan and your cash stays in stock.
- A working capital line bridges the 30 to 60 day HSE payment delay, and you only pay interest on what you actually draw.
- Lenders want a debt service coverage ratio (DSCR) of at least 1.25 from your dispensing income before they approve.
Why Pharmacies Get Declined (and How to Avoid It)
Your inventory is your biggest cost and your main asset, and it ties up €30,000 to €60,000 before you have dispensed a single script.
On top of that you carry registration, professional indemnity insurance and controlled-substance storage costs, and the HSE settles its share of every prescription 30 to 60 days after you hand the medicine over.
Lenders read that combination as risk and a lot of them stop reading there.
What they miss is that a pharmacy is one of the most stable cash businesses going. Prescription demand is constant, patient loyalty runs deep, and a busy community pharmacy doing 500 scripts a week generates reliable income month after month.
The job is to present your numbers so the lender sees the predictability, not just the working capital gap. This is exactly where our professional finance team earns its keep on a practice purchase.
Get this right and the decline reasons disappear. Most pharmacy applications fall down on three things: no cash flow forecast that accounts for the HSE delay, no clear DSCR, and an opening underfunded on inventory that runs out of stock and working capital in the same month.
What Lenders Actually Look For
The metric that matters is the debt service coverage ratio (DSCR).
On an acquisition the lender reads it straight from the accounts of the pharmacy you are buying: the €280,000 purchase loan above at €2,975 a month is €35,700 a year to service, so they want to see at least €44,625 of net practice profit sitting above that before they are comfortable.
That is the quiet advantage of buying an established dispensary over opening cold, because the earnings history is already on paper. A flat or declining script count is what weakens the ratio, not the headline price.
On the compliance side, expect no flexibility. Your VAT and tax returns must be filed and paid, or under an agreed arrangement with Revenue, evidenced by a current tax clearance certificate.
The lender will check your Central Credit Register record and want it clean or clearly under control, and a practice held in a limited company needs its CRO filings current.
Layered on top is your PSI registration, because the dispensary is worth nothing the day you cannot legally run it. Of all of these, outstanding Revenue debt is the item most likely to stop an otherwise strong application, so deal with it first.
The Financing Options That Actually Work
Pharmacy financing is not one product. The right structure depends on whether you are buying an established practice, fitting out a new one, upgrading the dispensary, or bridging the HSE payment gap.
1. Practice Acquisition Loans (€100k to €300k)
Use it when you are buying an established pharmacy: you borrow against the goodwill, inventory and equipment and repay over 7 to 10 years.
A Dublin acquisition recently combined a €200,000 purchase price, €50,000 of included inventory and equipment, and €30,000 of working capital for the first six months: €280,000 over 10 years at 5.5% works out at €2,975 a month.
The existing patient base means revenue lands from day one, which is why acquisitions reach full profitability in three to six months rather than a year.
2. Opening a New Pharmacy (€80k to €150k)
Use it to set up from scratch in a new location.
A Cork independent funded €25,000 of fit-out and renovation, €15,000 of pharmacy systems (POS and dispensing software), €40,000 of initial inventory, €8,000 of fixtures and shelving, and €20,000 of working capital: €108,000 over seven years at 6% comes to €1,625 a month.
A new practice takes 12 to 18 months to reach full profitability, so size the working capital for that ramp.
3. Dispensing Equipment and Systems Finance (€10k to €40k)
Use it to upgrade the dispensary: automated counters, POS and refrigeration for temperature-sensitive stock. The equipment is the security, so you repay over three to five years and keep your cash for inventory.
A practice financed a €20,000 automated dispensing counter, an €8,000 POS upgrade and €5,000 of pharmaceutical refrigeration: €33,000 over five years at 5.5% is €621 a month. This is exactly what our asset finance is built for.
4. SBCI-Backed Loans (€5k to €1m)
Use it to open or expand with limited collateral. The Strategic Banking Corporation of Ireland guarantees 80% of the loan, so a personal guarantee is enough up to €25,000 and the rates undercut a standard bank term loan.
A pharmacist opening a first practice took €20,000 of SBCI microfinance at 6% over five years, around €377 a month, with no property security required.
5. Working Capital Lines (€10k to €30k)
Use it to bridge the HSE payment delay. You dispense today and the scheme settles in 30 to 60 days, so a standby line covers the gap.
A pharmacy with a €15,000 line drew €8,000 when the scheme ran 60 days behind, then repaid the €8,000 plus interest (7%, roughly €28 a month) once the payment landed. The interest only runs on what is actually drawn.
How the Lenders Differ
- Pillar banks (AIB, Bank of Ireland, Permanent TSB): the strictest requirements, two years of accounts, six months of business statements, a current tax clearance cert and full CRO compliance. Slow and thorough, lending €20,000 to €300,000 over 5 to 10 years at 5 to 7%, but the best rates on a qualifying term loan.
- Alternative and fintech lenders: lighter touch, assessing affordability straight from three to six months of statement data rather than two years of filed accounts. Faster, higher rates, and the realistic route for a practice under two years old.
- SBCI-backed and pharmacy-specialist lenders: bank-level rates with more flexibility on security, lending €5,000 to €1m on the SBCI side and €50,000 to €300,000 over 7 to 10 years from the specialists who understand healthcare cash flow. They suit first-time owners buying their first practice.
What You Need Before You Apply
Walk in with a business plan that names the location, the target patient base and why the practice works; a professional valuation if you are buying (valuers typically apply a multiple of two to four times annual net profit to goodwill plus inventory); a 24-month cash flow forecast that shows the HSE delay honestly rather than hiding it; your PSI registration and qualifications; your personal credit report and a current tax clearance cert; and evidence of the location through a lease or purchase agreement.
Lenders fund pharmacists who clearly understand their own numbers, so the forecast is doing more work than any other document in the pack.
Final Thoughts
Pharmacy financing works the moment the lender understands the business instead of fearing the cash flow delay. You are not retail and you are not a typical service business: your income is delayed but, read correctly, deeply predictable.
Present the script volume, the patient base and the margins in their language and the risk story flips in your favour.
Buy the right practice at the right price, because a thriving pharmacy in a good location funds itself while a struggling one in a bad location does not improve with ownership.
Set the structure early: an acquisition loan plus a working capital line for the HSE delays, get 20 to 30% of the price together yourself, and borrow the rest.
And do not underfund the inventory, because €40,000 to €60,000 of stock, not a lack of patients, is what empties the shelves and the till in year one.
For a closely related angle, see our guide to Dental Practice Financing.
Frequently Asked Questions
Can I get financed without buying an established practice?
Yes. SBCI lenders and some banks fund new pharmacy openings if you have two or more years of pharmacy management behind you, a strong business plan and clean personal credit. They are noticeably more flexible than the pillar banks for first-time owners.
How do I value a pharmacy practice?
Professional valuers apply a multiple of two to four times annual net profit to the goodwill plus inventory. A pharmacy netting €18,000 a year might be valued at €36,000 to €72,000, before you add the cost of stock and equipment on the shelves.
What happens while I wait for HSE payments?
Put a working capital line of €10,000 to €30,000 in place as backup. Draw it when the scheme runs 30 to 60 days behind, repay it when the payment lands, and pay interest only on what you use.